Electrodiagnostic Testing (EDX) — NCV/NCS, Needle EMG, SSEP
Customize your policy alerts
Sign up for orthonet Policy 359 alerts
Get alerted when Policy 359 changes without checking for updates manually.
Monitor payer policy activity
Clinical criteria governing the appropriate use and medical necessity of electrodiagnostic testing (NCV/NCS, needle EMG, SSEP) for evaluation of neuromuscular disorders; applies to in- and out-of-network programs (excludes Medicare/Medicaid chiropractic products).
No material clinical or coverage changes in this revision.
Coverage Criteria for Electrodiagnostic Testing
Medically necessary EDX testing conditions
Covered when ALL of the following are met
See supporting examples and test-specific rules.
SSEP for other disorders is unproven.
Outside these circumstances, NCS without EMG are considered unproven.
NCS are usually performed first and concurrently followed by needle EMG; EMG complements NCS.
Unproven or Not Medically Necessary
Considered unproven / not medically necessary when ANY of the following apply
There is a high false-negative rate for SSEP in lumbar radiculopathy and inconsistent evidence for DSEP testing.
This policy applies to electrodiagnostic testing utilization review determinations for in-network and out-of-network programs. It explicitly excludes Medicare and Medicaid chiropractic products from its scope of applicability; providers billing under those products should follow applicable Medicare/Medicaid coverage rules instead.
The policy history documents periods of inactivation and subsequent reinstatement and multiple annual reviews, but the cited review history entries do not introduce additional explicit exclusion criteria beyond those stated in the Scope. Review and approval history should be consulted for versioning and administrative context, however it does not themselves list clinical exclusions beyond scope notes.
When performed with other studies, short-latency somatosensory evoked potentials (SSEP) are considered proven only for the listed central nervous system and perioperative indications; SSEP for disorders not listed is unproven/not medically necessary, and SSEP has a reported high false-negative rate (~65%) for lumbar radiculopathy so dermatomal/segmental SSEP (DSEP) is not supported for lumbosacral radiculopathy.
F-wave and H-reflex (late response) testing are commonly performed alongside nerve conduction studies but lack sufficient clinical utility when done in isolation; these late responses are not supported for diagnostic conclusions if performed without concurrent needle EMG and motor and sensory NCS.
Nerve conduction velocity/studies (NCV/NCS) may be performed without concurrent needle EMG only in specific circumstances (e.g., patients on anticoagulation, with bleeding/clotting disorders, with lymphedema, susceptible to recurrent systemic infections, or when evaluating carpal tunnel syndrome); outside those exceptions, NCV/NCS without concurrent needle EMG is considered unproven/not medically necessary.
Coding Information
| 95860 | Needle electromyography; 1 extremity with or without related paraspinal areas. |
| 95861 | Needle electromyography; 2 extremities with or without related paraspinal areas. |
| 95863 | Needle electromyography; 3 extremities with or without related paraspinal areas. |
| 95864 | Needle electromyography; 4 extremities with or without related paraspinal areas. |
| 95885 | Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited (List separately in addition to code for primary procedure). |
| 95886 | Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; complete, five or more muscles studied, innervated by three or more nerves or four or more spinal levels (List separately in addition to code for primary procedure). |
| 95907 | Nerve conduction studies; 1-2 studies. |
| 95908 | Nerve conduction studies; 3-4 studies. |
| 95909 | Nerve conduction studies; 5-6 studies. |
| 95910 | Nerve conduction studies; 7-8 studies. |
| 95860 | Needle electromyography; 1 extremity with or without related paraspinal areas. |
| 95861 | Needle electromyography; 2 extremities with or without related paraspinal areas. |
| 95863 | Needle electromyography; 3 extremities with or without related paraspinal areas. |
| 95864 | Needle electromyography; 4 extremities with or without related paraspinal areas. |
| 95885 | Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited (List separately in addition to code for primary procedure). |
| 95886 | Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; complete, five or more muscles studied, innervated by three or more nerves or four or more spinal levels (List separately in addition to code for primary procedure). |
| 95907 | Nerve conduction studies; 1-2 studies. |
| 95908 | Nerve conduction studies; 3-4 studies. |
| 95909 | Nerve conduction studies; 5-6 studies. |
| 95910 | Nerve conduction studies; 7-8 studies. |
Prior authorization / utilization management for listed CPT codes
Certain CPT codes for needle EMG, nerve conduction studies, and somatosensory evoked potentials listed in the policy are subject to utilization management and may require prior authorization per payer procedures; follow your payer's prior authorization process for these services.
- Covered/managed CPT codes include: 95860, 95861, 95863, 95864, 95885, 95886, 95907–95913, 95925–95927, and 95999 (as listed in the Coding Information).
- Policy governs utilization review for in- and out-of-network programs (excludes Medicare and Medicaid chiropractic products) and was updated to add a Documentation section on 04/22/2021.
Provider Actions, Documentation, and Prior Authorization
Prior authorization applies to in‑ and out‑of‑network programs
This policy governs utilization review determinations for both in-network and out-of-network programs (excluding Medicare and Medicaid chiropractic products); follow the payer's prior authorization process when requesting EDX services.
Testing sequence — perform NCS first, then needle EMG
Nerve conduction studies (NCS) are usually performed first and are followed by needle electromyography (EMG); EMG complements NCS and should be performed (concurrently or within two business days) unless contraindicated.
- Dissociation of NCS and EMG into separate reports is inappropriate unless specifically explained by the physician.
Provider billing action: document exceptions and use listed CPT codes
When ordering or billing EDX studies, ensure codes and services reflect the combined diagnostic approach (NCS + EMG) and any listed exceptions for NCS without EMG are documented.
- If NCS is performed without EMG, document an approved exception (e.g., anticoagulation, lymphedema, recurrent infections, carpal tunnel evaluation).
- Use the appropriate CPT codes from the policy coding list when submitting claims.
Document medical necessity in the medical record
Medical necessity for the electrodiagnostic procedure(s) must be documented and supported in the patient's medical record, including the need and scope of the study following a comprehensive history and neurological/neuromuscular exam.
Maintain complete EDX exam documentation
Providers should retain supporting documentation for electrodiagnostic studies as referenced in the policy (documentation section added 04/22/2021).
- Keep records of the comprehensive history, neurologic exam, and EDX study findings and interpretations.
Triggers for denial — screening, missing exam/history, post‑diagnosis, NCS without EMG
EDX studies performed for screening purposes, lacking a comprehensive history and complete neuromuscular exam, performed after a definitive diagnosis is established, or NCS performed without concurrent needle EMG (outside listed exceptions) are considered unproven and may be denied.
- Dermatomal/segmental SSEP for lumbosacral radiculopathy and sole use of F‑wave/H‑reflex without EMG/NCS are unproven and subject to denial.
Denial risk from noncompliance with policy and documentation
Absence of required documentation or nonconformance with coding and policy guidance may trigger utilization management actions; the policy is reviewed periodically and noncompliance can lead to denial or other review outcomes.
- Maintain documentation consistent with policy expectations and coding lists to avoid review actions.
Definitions and Test Descriptions
Background
Electrodiagnostic (EDX) testing documents electrical activity of the neuromuscular system and encompasses needle electromyography (EMG), nerve conduction studies (NCS/NCV), and somatosensory evoked potentials (SSEP). The exam is intended to extend a comprehensive history and neurological/neuromuscular examination and should be individualized and designed by a clinician knowledgeable in neurophysiology.
Needle EMG evaluates muscle electrical activity using needle electrodes and is described by CPT codes such as 95860–95864 and 95885–95886. Nerve conduction studies assess peripheral nerve function and are represented by CPT codes 95907–95913. Short-latency SSEP studies are represented by CPT codes 95925–95927 and assess afferent pathway integrity.
In routine practice, NCS are usually performed first and, unless contraindicated, should be performed concurrently with needle EMG (same session or within two business days) because the combination provides the gold-standard electrodiagnostic evaluation.
Policy Revision History
Utilization Management Committee approved inactivation of the policy.
Policy revised: retitled (Electrodiagnostic Testing), reformatted, and submitted to the Utilization Management Committee for approval.
Revised policy approved by the Quality Improvement Committee.
Annual review and approval completed.
Annual review and approval completed; updated section describing circumstances where NCV is appropriate.
Annual review and approval completed; Documentation section was added and References/Table 1 updated.
Annual review and approval completed; no significant clinical changes made and contact email updated.
Annual review completed; document content transitioned to a new policy template with no substantive clinical changes; approved by the Optum Clinical Guideline Advisory Committee.
Annual review completed with no substantive changes; approved by the Optum Quality Improvement Committee.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.